{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:31:51Z","timestamp":1784914311858,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008673","name":"Yasuda Memorial Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010905","name":"Illumina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10926"],"award-info":[{"award-number":["24K10926"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H04925"],"award-info":[{"award-number":["JP22H04925"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07689"],"award-info":[{"award-number":["21K07689"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ck0106581"],"award-info":[{"award-number":["JP22ck0106581"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ck0106956"],"award-info":[{"award-number":["JP24ck0106956"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cllc.2025.09.013","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:05:17Z","timestamp":1759341917000},"page":"671-679.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-8892","authenticated-orcid":false,"given":"Masaki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Ichiro","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenari","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke A.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riu","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Haeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Tsuchihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadamoto","family":"Zenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2025.09.013_bib0001","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijrobp.2019.09.013","article-title":"Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): the first nationwide retrospective study in Japan","volume":"106","author":"Ohnishi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.09.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109640","article-title":"Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG)","volume":"183","author":"Kubo","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jtho.2023.10.016","article-title":"Five-year survival outcomes after carbon-ion radiotherapy for operable stage I NSCLC: a Japanese national registry study (J-CROS-LUNG)","volume":"19","author":"Kubo","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.athoracsur.2017.07.048","article-title":"Stereotactic body radiation therapy versus surgery for early lung cancer among US veterans","volume":"105","author":"Bryant","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2025.09.013_bib0006","first-page":"758","article-title":"Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer","volume":"63","author":"Kishi","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.cllc.2025.09.013_bib0007","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/JTO.0000000000000483","article-title":"Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC","volume":"10","author":"van den Berg","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.21.01611","article-title":"Inoperable early-stage non-small-cell lung cancer: stereotactic ablative radiotherapy and rationale for systemic therapy","volume":"40","author":"Daly","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0009","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2025.09.013_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2025.09.013_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41586-020-2140-0","article-title":"Integrating genomic features for non-invasive early lung cancer detection","volume":"580","author":"Chabon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2025.09.013_bib0012","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2023.02.021","article-title":"Detection of pretreatment circulating tumor DNA predicts recurrence after high-dose proton beam therapy for early-stage non-small cell lung cancer","volume":"116","author":"Nakamura","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.09.013_bib0013","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2025.09.013_bib0014","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2019.05.013","article-title":"Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma","volume":"177","author":"Lee","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cllc.2025.09.013_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2013.06.047","article-title":"High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer","volume":"109","author":"Huang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0016","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0003-4975(02)03895-X","article-title":"Early\" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan","volume":"74","author":"Suzuki","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2025.09.013_bib0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"issue":"Supple","key":"10.1016\/j.cllc.2025.09.013_bib0018","article-title":"Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I\/II non-small-cell lung cancer (NSCLC): the randomized, double-blind, phase 3 KEYNOTE-867 study","volume":"24","author":"Pircher","year":"2024","journal-title":"Ann Oncol"},{"issue":"Supple","key":"10.1016\/j.cllc.2025.09.013_bib0019","article-title":"SWOG\/NRG S1914: randomized phase III trial of induction\/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC","volume":"43","author":"Simone","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s43018-019-0011-0","article-title":"Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small cell lung cancer","volume":"1","author":"Moding","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.cllc.2025.09.013_bib0021","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1158\/1078-0432.CCR-21-3044","article-title":"Perioperative ctDNA-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (LUNGCA-1)","volume":"28","author":"Xia","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2025.09.013_bib0022","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1200\/JCO.23.00258","article-title":"Early-stage lung cancer: using circulating tumor DNA to get personal","volume":"41","author":"Bestvina","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0023","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.annonc.2022.02.007","article-title":"Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer","volume":"33","author":"Gale","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0024","article-title":"Use and outcomes of SBRT for early stage NSCLC without pathologic confirmation in the Veterans Health Care Administration","volume":"6","author":"Wilkie","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2049-6958-9-53","article-title":"Patient reported experiences of CT guided lung biopsy: a prospective cohort study","volume":"9","author":"Winn","year":"2014","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.cllc.2025.09.013_bib0026","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.13-2924","article-title":"When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: a decision analysis","volume":"146","author":"Louie","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2025.09.013_bib0027","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12916-022-02681-x","article-title":"Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer","volume":"20","author":"Shen","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.cllc.2025.09.013_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115237","article-title":"Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer","volume":"217","author":"Hong","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2025.09.013_bib0029","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","article-title":"Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA","volume":"616","author":"Abbosh","year":"2023","journal-title":"Nature"},{"issue":"in press","key":"10.1016\/j.cllc.2025.09.013_bib0030","article-title":"Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer","author":"Jardali","year":"2025","journal-title":"Diag Interv Img"},{"key":"10.1016\/j.cllc.2025.09.013_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.annonc.2023.11.008","article-title":"Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer","volume":"35","author":"Tran","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2025.09.013_bib0032","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/s41467-024-47512-0","article-title":"Enhancing NSCLC recurrence prediction with PET\/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights","volume":"15","author":"Sujit","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cllc.2025.09.013_bib0033","first-page":"277","volume":"47","author":"Kimura","year":"2017","journal-title":"Jpn J Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425002384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425002384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:57:41Z","timestamp":1773820661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425002384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525730425002384"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.09.013","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}